Literature DB >> 6996796

A study of the effect of acute systemic anaphylaxis on blood coagulation and TAME esterase activity in calves.

W D Black, P A Gentry.   

Abstract

Sensitized and control calves were challenged with an intravenous dose of 0.2 mL/kg horse serum. Changes in the blood pressure, blood cellular components, plasma kaolin activated p-tosyl-1-arginine methyl ester esterase activity, plasma antithrombin III levels and activated partial thromboplastin time were monitored. Anaphylaxis induced a severe drop in carotid arterial pressure and respiratory distress. There was a decrease in the total white blood cell count from a mean of 10,000 to a low of 1,900 per microL, a decrease in the percentage neutrophils and an increase in the percentage of lymphocytes from 57.4% to 94.8%. A drop was observed in the mean platelet count from 463 x 10(3)/microL. The time required for kaolin to produce maximum p-tosyl-1-arginine methyl ester esterase activation increased from two minutes in the controls to three minutes in calves undergoing anaphylaxis and was observed three to 90 minutes after the administration of horse serum. Antithrombin III levels in the plasma appeared to drop during anaphylaxis but were not significantly depressed (p greater than or equal to 0.5). A statistically significant (p < 0.5) drop in the rate of blood coagulation was observed by the activated partial thromboplastin time assay at 15 to 30 minutes after horse serum injection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6996796      PMCID: PMC1320049     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  23 in total

1.  Plasma antithrombin III: a quantitative assay of biological activity.

Authors:  S A Gitel; S Wessler
Journal:  Thromb Res       Date:  1975-07       Impact factor: 3.944

2.  Inhibition of bovine factor IXa and factor Xabeta by antithrombin III.

Authors:  K Kurachi; K Fujikawa; G Schmer; E W Davie
Journal:  Biochemistry       Date:  1976-01-27       Impact factor: 3.162

Review 3.  General considerations of coagulation proteins.

Authors:  D Green
Journal:  Ann Clin Lab Sci       Date:  1978 Mar-Apr       Impact factor: 1.256

4.  Bovine thrombin and activated factor X. Separation and purification.

Authors:  E T Yin; S Wessler
Journal:  J Biol Chem       Date:  1968-01-10       Impact factor: 5.157

5.  Experimental anaphylaxis in cattle.

Authors:  M M Aitken; J Sanford
Journal:  J Comp Pathol       Date:  1969-01       Impact factor: 1.311

6.  3H-heparin and antithrombin III in the isolated liver perfusion.

Authors:  R Losito; G Barlow; E Lemieux
Journal:  Thromb Res       Date:  1977-01       Impact factor: 3.944

7.  Inhibition of activated factor XII by antithrombin-heparin cofactor.

Authors:  N Stead; A P Kaplan; R D Rosenberg
Journal:  J Biol Chem       Date:  1976-11-10       Impact factor: 5.157

8.  Interaction of heparin with canine coagulation proteins: in vivo and in vitro studies.

Authors:  P A Gentry
Journal:  Can J Comp Med       Date:  1977-10

9.  Study of TAMe (p-tosyl-L-arginine methyl ester) esterase activity of bovine plasma.

Authors:  J Claxton; W D Black; P A Gentry
Journal:  Am J Vet Res       Date:  1978-07       Impact factor: 1.156

10.  Heparin-induced decrease in circulating antithrombin-III.

Authors:  E Marciniak; J P Gockerman
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.